Über das Unternehmen
- Firmenname (rechtlich): Shanghai SynFarm Pharmaceutical Technology Co., Ltd.
- Internationaler Name: 上海升华医药科技有限公司 (Shanghai SynFarm Pharmaceutical Technology Co., Ltd.), Shanghai, China
- Marke / Handelsname: SynFarm
- Registrierungsland: China
- Adresse: Shanghai
Beschreibung:
Founded in 2009, Shanghai SynFarm Pharmaceutical Technology Co., Ltd. (synfarm.com) manufactures antiviral and specialty active pharmaceutical ingredients, including sofosbuvir, posaconazole, ibrutinib (and its N-3 intermediate), and dolutegravir, supported by synthetic building blocks such as protected hydroxypiperidines and a deoxy-fluoro-methyluridine nucleoside analog. Its GMP-compliant plant base is designed to handle multi-scale production for global contract research and manufacturing work. Categorized under chiral intermediates, the company sells across North and South America, Western and Eastern Europe, Australasia, Asia, the Middle East and Africa.
Geschäftsaktivitäten
Pharmazeutische Chemikalien
LieferantAnbieter für AuftragssyntheseAPI-Hersteller
Pharmazeutische Wirkstoffe (API)
API-Hersteller
Absatzmärkte
- Western Europe: Austria, Belgium, France
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Hauptprodukte/-dienstleistungen
- Vertrags- & Outsourcing-Dienstleistungen: Custom Synthesis
- Pharmazeutische Chemikalien: Posaconazole, Sofosbuvir, Pharmaceutical Intermediates, 1-Boc-3-piperidone, 5-Amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile; Ibrutinib N-3, Ibrutinib, 4-Phenoxybenzoic acid, 2’-deoxy-2’-fluoro-2’-C-methyluridine, 3-Hydroxypiperidine, Dolutegravir
Unsere Produkte & Dienstleistungen
Certifications
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen